image
Day One Biopharmaceuticals, Inc. DAWN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.32
-1.4 %
$ 641 M
Market Cap
-9.72
P/E
Price Target Average
448.52%
Revenue Forecast Estimate
49.68%
EBIT Estimate
39.78%
Net Income Estimate
40.24%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Day One Biopharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for DAWN of $34.7 , with forecasts ranging from a low of $24 to a high of $45 .
DAWN Lowest Price Target Wall Street Target
24 USD 279.75%
DAWN Average Price Target Wall Street Target
34.7 USD 448.52%
DAWN Highest Price Target Wall Street Target
45 USD 612.03%
Price
Max Price Target
Min Price Target
Average Price Target
4545404035353030252520201515101055Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart DAWN

image
$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.020232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart DAWN

image
$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart DAWN

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)20232023202420242025202520262026202720272028202820292029